Sign In
to Vote &
Create Storyboards.
 
Shares of Valeant Pharmaceuticals International Inc. (NYSE:VRX) suffered late Thursday on news that health chain CVS had severed ties with a specialty pharmacy whose convoluted relationship with Valeant has stirred shareholder unrest in the past week. The news, reported by Dow Jones, comes as executives try to right the ship after a spate of damaging reports.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard